<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35585293</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1933-7205</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Reproductive sciences (Thousand Oaks, Calif.)</Title>
          <ISOAbbreviation>Reprod Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>P450 Side-Chain Cleavage Enzyme (P450-SCC) Is an Ovarian Autoantigen in a Mouse Model for Autoimmune Oophoritis.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s43032-022-00970-7</ELocationID>
        <Abstract>
          <AbstractText>Steroid-producing cells contain key cytochrome P450 enzymes, such as side-chain cleavage (P450-SCC) and 17α-hydroxylase (17α-OH). They are required for steroid hormone synthesis and considered antigens associated with Addison's disease and autoimmune primary ovarian insufficiency (POI). We studied an animal model for human autoimmune POI in mice with autoimmune oophoritis induced by neonatal thymectomy performed at day 3 (TX3). We previously identified an oocyte-specific protein as a major antigen inciting autoimmune oophoritis in mice. In this study, we characterized ovarian steroid-producing cell antigens. Using indirect immunofluorescence staining, we tested immune reactions in mouse ovarian and adrenal tissue sections with sera from TX3 female mice. More than half of the TX3 mice (8 of 15) produced antibodies reacting with both ovarian and adrenal steroid-producing cells, including some that reacted to oocytes as well. We produced recombinant proteins for the three key steroidogenic enzymes 17α-OH, P450-SSC, and 3β-hydroxysteroid dehydrogenase (3β-HSD) and tested their immune reactions with individual mouse sera. By immunoblotting, all mouse sera that reacted with the steroid-producing cells (n = 8) were shown to react with the P450-SCC, but not with the 17α-OH or 3β-HSD recombinant proteins. The sham-operated mouse sera and TX3 mouse sera negative for steroid-producing cells did not react with the P450-SCC recombinant protein. Our findings indicate that the P450-SCC is a specific and unique major antigen within the ovarian steroid-producing cells. Given their similarity of predicted antigenicity, we assume that P450-SCC acts in human autoimmune POI as it does in mouse autoimmune oophoritis.</AbstractText>
          <CopyrightInformation>© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Zhi-Bin</ForeName>
            <Initials>ZB</Initials>
            <Identifier Source="ORCID">0000-0002-4224-2548</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA. tongz@mail.nih.gov.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Reproductive Biology and Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. tongz@mail.nih.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Otsuka</LastName>
            <ForeName>Noriyuki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Biology and Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Graduate School of Medicine/Faculty of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tu</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Biology and Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Viral Products, CBER, FDA, Silver Spring, MD, 20993, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Qingxiang</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Biology and Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Global Biopharma Development, Incyte, Wilmington, DE, 19803, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeCherney</LastName>
            <ForeName>Alan H</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Reproductive Biology and Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Reprod Sci</MedlineTA>
        <NlmUniqueID>101291249</NlmUniqueID>
        <ISSNLinking>1933-7191</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Animal model</Keyword>
        <Keyword MajorTopicYN="N">Autoimmune oophoritis</Keyword>
        <Keyword MajorTopicYN="N">Neonatal thymectomy</Keyword>
        <Keyword MajorTopicYN="N">P450-SCC</Keyword>
        <Keyword MajorTopicYN="N">POI</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>23</Hour>
          <Minute>30</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35585293</ArticleId>
        <ArticleId IdType="doi">10.1007/s43032-022-00970-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s43032-022-00970-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gonzalez FJ, Gelboin HV. Human cytochromes P450: evolution and cDNA-directed expression. Environ Health Perspect. 1992;98:81–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1486867</ArticleId>
            <ArticleId IdType="pmc">1519618</ArticleId>
            <ArticleId IdType="doi">10.1289/ehp.929881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamb DC, Lei L, Warrilow AG, Lepesheva GI, Mullins JG, Waterman MR, et al. The first virally encoded cytochrome p450. J Virol. 2009;83(16):8266–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19515774</ArticleId>
            <ArticleId IdType="pmc">2715754</ArticleId>
            <ArticleId IdType="doi">10.1128/JVI.00289-09</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002;3(6):561–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12369887</ArticleId>
            <ArticleId IdType="doi">10.2174/1389200023337054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guengerich FP. Intersection of the roles of cytochrome P450 enzymes with xenobiotic and endogenous substrates: relevance to toxicity and drug interactions. Chem Res Toxicol. 2017;30(1):2–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27472660</ArticleId>
            <ArticleId IdType="doi">10.1021/acs.chemrestox.6b00226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanukoglu I. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol. 1992;43(8):779–804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22217824</ArticleId>
            <ArticleId IdType="doi">10.1016/0960-0760(92)90307-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25(6):947–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15583024</ArticleId>
            <ArticleId IdType="doi">10.1210/er.2003-0030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frye CA. Steroids, reproductive endocrine function, and affect. A review Minerva Ginecol. 2009;61(6):541–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19942840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcinkowska E, Wiedlocha A. Steroid signal transduction activated at the cell membrane: from plants to animals. Acta Biochim Pol. 2002;49(3):735–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12422243</ArticleId>
            <ArticleId IdType="doi">10.18388/abp.2002_3782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet. 2019;36(11):2207–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31440958</ArticleId>
            <ArticleId IdType="pmc">6885484</ArticleId>
            <ArticleId IdType="doi">10.1007/s10815-019-01572-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson C. Autoimmunity: autoimmune Addison disease and premature ovarian failure. Nat Rev Endocrinol. 2011;7(9):498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21750509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J Clin Invest. 1993;92(5):2377–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8227354</ArticleId>
            <ArticleId IdType="pmc">288420</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI116843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23(3):327–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12050123</ArticleId>
            <ArticleId IdType="doi">10.1210/edrv.23.3.0466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muir A, Schatz DA, Maclaren NK. Autoimmune Addison’s disease. Springer Semin Immunopathol. 1993;14(3):275–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8438210</ArticleId>
            <ArticleId IdType="doi">10.1007/BF00195978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weetman AP. Autoantigens in Addison’s disease and associated syndromes. Clin Exp Immunol. 1997;107(2):227–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9030856</ArticleId>
            <ArticleId IdType="pmc">1904566</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1365-2249.1997.1137a.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison’s disease, and premature ovarian failure. J Clin Endocrinol Metab. 1996;81(5):1871–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8626850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab. 1994;78(2):323–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8106620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison’s disease and autoimmune polyendocrine syndrome type II. Exp Clin Endocrinol Diabetes. 1999;107(3):208–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10376448</ArticleId>
            <ArticleId IdType="doi">10.1055/s-0029-1212100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19196677</ArticleId>
            <ArticleId IdType="pmc">2762081</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJMcp0808697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalantaridou SN, Nelson LM. Autoimmune premature ovarian failure: of mice and women. J Am Med Womens Assoc (1972). 1998;53(1):18–20.</Citation>
        </Reference>
        <Reference>
          <Citation>Domniz N, Meirow D. Premature ovarian insufficiency and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol. 2019;60:42–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31495598</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bpobgyn.2019.07.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod. 2002;17(8):2096–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12151443</ArticleId>
            <ArticleId IdType="doi">10.1093/humrep/17.8.2096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014;10(1):37–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24189508</ArticleId>
            <ArticleId IdType="doi">10.1038/nrendo.2013.212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taguchi O, Nishizuka Y, Sakakura T, Kojima A. Autoimmune oophoritis in thymectomized mice: detection of circulating antibodies against oocytes. Clin Exp Immunol. 1980;40(3):540–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6998618</ArticleId>
            <ArticleId IdType="pmc">1538942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tung KS, Smith S, Matzner P, Kasai K, Oliver J, Feuchter F, et al. Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy. Autoantibodies Am J Pathol. 1987;126(2):303–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3826296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong ZB, Nelson LM. A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology. 1999;140(8):3720–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10433232</ArticleId>
            <ArticleId IdType="doi">10.1210/endo.140.8.6911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong ZB, Nelson LM, Dean J. Mater encodes a maternal protein in mice with a leucine-rich repeat domain homologous to porcine ribonuclease inhibitor. Mamm Genome. 2000;11(4):281–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10754103</ArticleId>
            <ArticleId IdType="doi">10.1007/s003350010053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet. 2000;26(3):267–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11062459</ArticleId>
            <ArticleId IdType="doi">10.1038/81547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otsuka N, Tong ZB, Vanevski K, Tu W, Cheng MH, Nelson LM. Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater. Endocrinology. 2011;152(6):2465–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21447630</ArticleId>
            <ArticleId IdType="pmc">3100611</ArticleId>
            <ArticleId IdType="doi">10.1210/en.2011-0022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong ZB, Bondy CA, Zhou J, Nelson LM. A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum Reprod. 2002;17(4):903–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11925379</ArticleId>
            <ArticleId IdType="doi">10.1093/humrep/17.4.903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alimohammadi M, Bjorklund P, Hallgren A, Pontynen N, Szinnai G, Shikama N, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358(10):1018–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18322283</ArticleId>
            <ArticleId IdType="doi">10.1056/NEJMoa0706487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alard P, Thompson C, Agersborg SS, Thatte J, Setiady Y, Samy E, et al. Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy. J Immunol. 2001;166(7):4363–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11254690</ArticleId>
            <ArticleId IdType="doi">10.4049/jimmunol.166.7.4363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Docherty LE, Rezwan FI, Poole RL, Turner CL, Kivuva E, Maher ER, et al. Mutations in NLRP5 are associated with reproductive wastage and multilocus imprinting disorders in humans. Nat Commun. 2015;6:8086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26323243</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms9086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mu J, Wang W, Chen B, Wu L, Li B, Mao X, et al. Mutations in NLRP2 and NLRP5 cause female infertility characterised by early embryonic arrest. J Med Genet. 2019;56(7):471–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30877238</ArticleId>
            <ArticleId IdType="doi">10.1136/jmedgenet-2018-105936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Qian Y, Liu Y, Wang Q, Wang R, Zhou Y, et al. A novel homozygous variant in NLRP5 is associate with human early embryonic arrest in a consanguineous Chinese family. Clin Genet. 2020;98(1):69–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32222962</ArticleId>
            <ArticleId IdType="doi">10.1111/cge.13744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sjodin K, Dalmasso AP, Smith JM, Martinez C. Thymectomy in newborn and adult mice. Transplantation. 1963;1:521–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14071261</ArticleId>
            <ArticleId IdType="doi">10.1097/00007890-196301040-00011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45(W1):W24–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28472356</ArticleId>
            <ArticleId IdType="pmc">5570230</ArticleId>
            <ArticleId IdType="doi">10.1093/nar/gkx346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006;2:2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16635264</ArticleId>
            <ArticleId IdType="pmc">1479323</ArticleId>
            <ArticleId IdType="doi">10.1186/1745-7580-2-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paul S, LindestamArlehamn CS, Scriba TJ, Dillon MB, Oseroff C, Hinz D, et al. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. J Immunol Methods. 2015;422:28–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25862607</ArticleId>
            <ArticleId IdType="pmc">4458426</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jim.2015.03.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair S, Mastorakos G, Raj S, Nelson LM. Murine experimental autoimmune oophoritis develops independently of gonadotropin stimulation and is primarily localized in the stroma and theca. Am J Reprod Immunol. 1995;34(2):132–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8526990</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1600-0897.1995.tb00929.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raj S, Nair S, Mastorakos G, Nelson LM. Anamnestic development of lymphocytic infiltration in murine experimental autoimmune oophoritis is primarily localized in the stroma and theca. Am J Reprod Immunol. 1995;34(2):125–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8526989</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1600-0897.1995.tb00928.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest. 1976;34(6):550–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">947081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996;6(1):1–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8845856</ArticleId>
            <ArticleId IdType="doi">10.1097/00008571-199602000-00002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 1992;89(1):283–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1370298</ArticleId>
            <ArticleId IdType="pmc">442846</ArticleId>
            <ArticleId IdType="doi">10.1172/JCI115573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013;2013: 509764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23878745</ArticleId>
            <ArticleId IdType="pmc">3710642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong ZB, Gold L, De Pol A, Vanevski K, Dorward H, Sena P, et al. Developmental expression and subcellular localization of mouse MATER, an oocyte-specific protein essential for early development. Endocrinology. 2004;145(3):1427–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14670992</ArticleId>
            <ArticleId IdType="doi">10.1210/en.2003-1160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmasso AP, Martinez C, Sjodin K, Good RA. Studies on the role of the thymus in immunobiology; reconstitution of immunologic capacity in mice thymectomized at birth. J Exp Med. 1963;118:1089–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14112268</ArticleId>
            <ArticleId IdType="pmc">2137693</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.118.6.1089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 1985;161(1):72–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3871469</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.161.1.72</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982;156(6):1577–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6983558</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.156.6.1577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samy ET, Parker LA, Sharp CP, Tung KS. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med. 2005;202(6):771–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16172257</ArticleId>
            <ArticleId IdType="pmc">2212949</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.20041033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wickenheisser JK, Biegler JM, Nelson-Degrave VL, Legro RS, Strauss JF 3rd, McAllister JM. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS ONE. 2012;7(11): e48963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23155436</ArticleId>
            <ArticleId IdType="pmc">3498373</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0048963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ong M, Cheng J, Jin X, Lao W, Johnson M, Tan Y, et al. Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells. J Ethnopharmacol. 2019;229:97–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30195059</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jep.2018.09.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su YQ, Nyegaard M, Overgaard MT, Qiao J, Giudice LC. Participation of mitogen-activated protein kinase in luteinizing hormone-induced differential regulation of steroidogenesis and steroidogenic gene expression in mural and cumulus granulosa cells of mouse preovulatory follicles. Biol Reprod. 2006;75(6):859–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16943367</ArticleId>
            <ArticleId IdType="doi">10.1095/biolreprod.106.052613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure. Fertil Steril. 2005;84(4):958–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16213850</ArticleId>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2005.04.060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson LM. Autoimmune ovarian failure: comparing the mouse model and the human disease. J Soc Gynecol Investig. 2001;8(1 Suppl Proceedings):S55-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11223375</ArticleId>
            <ArticleId IdType="doi">10.1177/1071557601008001S17</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
